REDDSTAR plenary meeting to be held in Berlin on Nov 5 and 6

NewsGuard 100/100 Score

'Diabetes- can stem cells help?' is a free, public event that will be held on Monday, 4 November 2013 from 19:00- 20:30 at The Ruin located within the Berlin Museum of Medical History, Charité. Diabetes and stem cell researchers from around Europe will assemble for a REDDSTAR plenary meeting hosted by Charité in Berlin on November 5 and 6th.  In conjunction with the scientific meeting, the public event will take place.  REDDSTAR, Repair of Diabetic Damage by Stromal Cell Administration involves ten partners from academia, industry and hospitals and runs for three years with funding from the European Commission. 

Speakers include Professor Doctor Hans- Dieter Volk, Director of the Berlin Brandenburg Center for Regenerative Therapy (BCRT), Professor Doctor Carsten Tschoepe of Charité and Mrs Michaela Berger, Board member for DiabetesDE.  The event will be moderated by Katharina Simons of the EU project CommHERE (www.CommHERE.eu).

Fifty million patients with diabetes mellitus in the EU are using prescription drugs to control their blood glucose levels. Poor control of blood glucose levels leads to a number of diabetic complications, including: nephropathy, retinopathy, cardiomyopathy, neuropathy, impaired bone repair and wound ulceration. At present, there are few therapeutic options available to control initiation and progression of diabetic complications and they continue to present challenging disease management issues for clinicians.  What is research doing to address this challenge?

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New microfluidic device improves the separation of tumor cells and clusters from malignant effusions